img

Topical Corticosteroids Market Status and Trend Analysis 2017-2034 (COVID-19 Version)


Published on: 2024-01-04 | No of Pages : 92 | Industry : Life & Medical

Publisher : 9 | Format : PDF

Topical Corticosteroids Market Status and Trend Analysis 2017-2034 (COVID-19 Version)

Summary

Further key aspects of the report indicate that
Chapter 1Research ScopeProduct Definition, Type, End-Use & Methodology
Chapter 2Global Industry Summary
Chapter 3Market Dynamics
Chapter 4Global Market Segmentation by region, type and End-Use
Chapter 5North America Market Segmentation by region, type and End-Use
Chapter 6Europe Market Segmentation by region, type and End-Use
Chapter 7Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8South America Market Segmentation by region, type and End-Use
Chapter 9Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10Market Competition by Companies
Chapter 11Market forecast and environment forecast.
Chapter 12Industry Summary.

The global Topical Corticosteroids market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.


Based on the type of product

the global Topical Corticosteroids market segmented into
Ointments
Creams
Others

Based on the end-use

the global Topical Corticosteroids market classified into
Hospitals
Dermatology Clinics
Pharmacies
Others

Based on geography

the global Topical Corticosteroids market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are


AstraZeneca plc
GlaxoSmithKline plc
Merck & Co., Inc.
Pfizer Inc.
Sandoz AG (Novartis AG)
Sanofi S.A.
Actimis Pharmaceuticals
Valeant Pharmaceuticals
Almirall, S.A
Zylera Pharmaceuticals

Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TOPICAL CORTICOSTEROIDS INDUSTRY
2.1 Summary about Topical Corticosteroids Industry
2.2 Topical Corticosteroids Market Trends
2.2.1 Topical Corticosteroids Production & Consumption Trends
2.2.2 Topical Corticosteroids Demand Structure Trends
2.3 Topical Corticosteroids Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Ointments
4.2.2 Creams
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Dermatology Clinics
4.3.3 Pharmacies
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Ointments
5.2.2 Creams
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Dermatology Clinics
5.3.3 Pharmacies
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Ointments
6.2.2 Creams
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Dermatology Clinics
6.3.3 Pharmacies
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Ointments
7.2.2 Creams
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Dermatology Clinics
7.3.3 Pharmacies
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Ointments
8.2.2 Creams
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Dermatology Clinics
8.3.3 Pharmacies
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Ointments
9.2.2 Creams
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Dermatology Clinics
9.3.3 Pharmacies
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AstraZeneca plc
10.1.2 GlaxoSmithKline plc
10.1.3 Merck & Co., Inc.
10.1.4 Pfizer Inc.
10.1.5 Sandoz AG (Novartis AG)
10.1.6 Sanofi S.A.
10.1.7 Actimis Pharmaceuticals
10.1.8 Valeant Pharmaceuticals
10.1.9 Almirall, S.A
10.1.10 Zylera Pharmaceuticals
10.2 Topical Corticosteroids Sales Date of Major Players (2017-2020e)
10.2.1 AstraZeneca plc
10.2.2 GlaxoSmithKline plc
10.2.3 Merck & Co., Inc.
10.2.4 Pfizer Inc.
10.2.5 Sandoz AG (Novartis AG)
10.2.6 Sanofi S.A.
10.2.7 Actimis Pharmaceuticals
10.2.8 Valeant Pharmaceuticals
10.2.9 Almirall, S.A
10.2.10 Zylera Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Topical Corticosteroids Product Type Overview
Table Topical Corticosteroids Product Type Market Share List
Table Topical Corticosteroids Product Type of Major Players
Table Brief Introduction of AstraZeneca plc
Table Brief Introduction of GlaxoSmithKline plc
Table Brief Introduction of Merck & Co., Inc.
Table Brief Introduction of Pfizer Inc.
Table Brief Introduction of Sandoz AG (Novartis AG)
Table Brief Introduction of Sanofi S.A.
Table Brief Introduction of Actimis Pharmaceuticals
Table Brief Introduction of Valeant Pharmaceuticals
Table Brief Introduction of Almirall, S.A
Table Brief Introduction of Zylera Pharmaceuticals
Table Products & Services of AstraZeneca plc
Table Products & Services of GlaxoSmithKline plc
Table Products & Services of Merck & Co., Inc.
Table Products & Services of Pfizer Inc.
Table Products & Services of Sandoz AG (Novartis AG)
Table Products & Services of Sanofi S.A.
Table Products & Services of Actimis Pharmaceuticals
Table Products & Services of Valeant Pharmaceuticals
Table Products & Services of Almirall, S.A
Table Products & Services of Zylera Pharmaceuticals
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Topical Corticosteroids Market Forecast (Million USD) by Region 2021f-2026f
Table Global Topical Corticosteroids Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Topical Corticosteroids Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Topical Corticosteroids Market Forecast (Million USD) Share by Demand 2021f-2026f